Age-related outcome for peripheral thrombolysis

European Journal of Vascular and Endovascular Surgery

Volumn 17, Issue 2, 1999, Pages 144-148

  Trkulja, D ^a   Fox, A D ^a   Budd, J S ^a   Chalmers, A H ^a   Horrocks, M ^a  

^a ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

Age; Amputation; Smoking; Thrombolysis

Indexed keywords

ALTEPLASE; HEPARIN;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; FEMALE; HUMAN; LEG AMPUTATION; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENESCENCE; SMOKING; TREATMENT OUTCOME;

EID: 0033082838     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.1998.0722     Document Type: Article

References (15)

1. Fogarty T.J., Cranley J.J., Krause R.J., Strasser E.S., Hafner C.D. A method for extraction of arterial emboli and thrombi. Sur Gyn Obs. 116:1963;241-249.
2. Braithwaite B.D., Earnshaw J.J. Arterial embolectomy: a century and out. Br J Surg. 81:1994;1705-1706.
3. Braithwaite B.D., Davies B., Birch P.A., Heather B.P., Earnshaw J.J. Management of acute leg ischaemia in the elderly. Br J Surg (Suppl.). 83:1996;33.
4. Dotter C.T., Rosch J., Seaman A.J. Selective clot lysis with low-dose streptokinase. Radiology. 111:1974;31-37.
5. Hess H. Thrombolytic therapy in peripheral vascular disease. Br J Surg. 77:1990;1083-1084.
6. Lonsdale R.J., Berridge D.C., Earnshaw J.J. Recombinant tissue-type plasminogen activator is superior to streptokinase for local intra-arterial thrombolysis. Br J Surg. 79:1992;272-275.
7. Earnshaw J.J., Scott D.J.A., Horrocks M., Baird R.N. Choice of agent for peripheral thrombolysis. Br J Surg. 80:1993;25-27.
8. Hess H., Ingrisch H., Meitaschk A., Rath H. Local low-dose thrombolytic therapy of peripheral arterial occlusions. N Engl J Med. 307:1982;1627-1630.
9. Hess H., Meitaschk A., Bruckl R. Peripheral arterial occlusions: a 6-year experience with local low-dose thrombolytic therapy. Interventional Radiology. 163:1987;753-758.
10. Doyle E., Britto J., Freeman J., Munro F., Morton N.S. Thrombolysis with low dose tissue plasminogen activator. Archives of Diseases in Children. 67:1992;1483-1484.
11. Maynard C., Weaver W.D., Lambrew C., Bowlby L.J., Rogers W.J., Rubison M. Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator. Am J Card. 76:1995;548-552.
12. Ellis P.K., Kelly B.E., McIlrath E.M. The use of recombinant human tissue type plasminogen activator in both graft and native arteries in the lower limb: results over a 2-year period. J Int Rad. 11:1996;145-147.
13. Beard J.D., Nyamekye I., Earnshaw J.J., Scott D.J.A., Thompson J.F. Intraoperative streptokinase: a useful adjunct to balloon-catheter embolectomy. Br J Surg. 80:1993;21-24.
14. Yusuf S.W., Whitaker S.C., Gregson R.H.S., Wenham P.W., Hopkinson B.R., Makin G.S. Immediate and early follow-up results of pulse spray thrombolysis in patients with peripheral ischaemia. Br J Surg. 82:1995;338-340.
15. Browse D.J., Torrie E.P.H., Galland R.B. Early results and 1-year follow up after intra-arterial thrombolysis. Br J Surg. 80:1993;194-197.